ES2643892T3 - Uso de micelas de proteínas de suero de leche para niños pequeños en riesgo de obesidad o diabetes - Google Patents

Uso de micelas de proteínas de suero de leche para niños pequeños en riesgo de obesidad o diabetes Download PDF

Info

Publication number
ES2643892T3
ES2643892T3 ES12775022.2T ES12775022T ES2643892T3 ES 2643892 T3 ES2643892 T3 ES 2643892T3 ES 12775022 T ES12775022 T ES 12775022T ES 2643892 T3 ES2643892 T3 ES 2643892T3
Authority
ES
Spain
Prior art keywords
diabetes
risk
whey protein
obesity
protein micelles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12775022.2T
Other languages
English (en)
Inventor
Catherine Mace
Lionel Jean René Bovetto
Etienne Pouteau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47045036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2643892(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec SA filed Critical Nestec SA
Application granted granted Critical
Publication of ES2643892T3 publication Critical patent/ES2643892T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Uso de las micelas de proteínas de suero de leche para tratar y/o prevenir un trastorno relacionado con un incremento de la secreción de insulina y/o de la concentración plasmática de IGF-1 en un niño pequeño que tenga el riesgo de desarrollar obesidad o diabetes.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES12775022.2T 2011-10-21 2012-10-19 Uso de micelas de proteínas de suero de leche para niños pequeños en riesgo de obesidad o diabetes Active ES2643892T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11186141.5A EP2583562A1 (en) 2011-10-21 2011-10-21 Use of whey protein micelles for infants at risk of obesity or diabetes
EP11186141 2011-10-21
PCT/EP2012/070718 WO2013057233A1 (en) 2011-10-21 2012-10-19 Use of whey protein micelles for infants at risk of obesity or diabetes

Publications (1)

Publication Number Publication Date
ES2643892T3 true ES2643892T3 (es) 2017-11-27

Family

ID=47045036

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12775022.2T Active ES2643892T3 (es) 2011-10-21 2012-10-19 Uso de micelas de proteínas de suero de leche para niños pequeños en riesgo de obesidad o diabetes

Country Status (10)

Country Link
US (1) US10028978B2 (es)
EP (2) EP2583562A1 (es)
CN (1) CN103906440B (es)
AU (1) AU2012324887B2 (es)
BR (1) BR112014009225A8 (es)
CL (1) CL2014000865A1 (es)
ES (1) ES2643892T3 (es)
MX (1) MX350866B (es)
RU (1) RU2616525C2 (es)
WO (1) WO2013057233A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
TR201816481T4 (tr) * 2013-11-01 2018-11-21 Nutricia Nv Yakalama büyümesi sırasında vücut bileşimini geliştirmek için lipit bileşimler.
CN105764355A (zh) * 2013-11-25 2016-07-13 雀巢产品技术援助有限公司 乳基营养组合物与胃部不适
ES2729757T3 (es) * 2013-11-29 2019-11-06 Nestle Sa Uso de composiciones nutritivas que tienen un reducido contenido de proteínas
MX2016006882A (es) * 2013-11-29 2016-08-17 Nestec Sa Nutricion infantil para el mejoramiento en la sensibilidad a la insulina mas adelante en la vida.
WO2015085555A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. Array of age-tailored infant formula with optimum protein content and lactose content
EP3361885B1 (en) 2015-10-15 2019-05-29 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
US20240180860A1 (en) 2016-12-09 2024-06-06 N.V. Nutricia Nutritional composition for improving cell membranes
EP3568028B1 (en) * 2017-01-11 2022-11-16 Société des Produits Nestlé S.A. Use of whey protein micelles and a source of casein for liquid spoonable nutritional compositions
AU2018227125A1 (en) * 2017-03-03 2019-10-24 Morinaga Milk Industry Co., Ltd. GLP-1 secretagogue and composition
EP4356961A2 (en) * 2019-06-13 2024-04-24 Société des Produits Nestlé S.A. Use of whey protein micelles for controlling postprandial glucose response
CA3156527A1 (en) * 2019-11-08 2021-05-14 Jose Maria Lopez Pedrosa Bovine milk-isolated powdered exosomes, nutritional compositions and methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
MXPA00002122A (es) * 1997-08-29 2003-06-09 Ricex Company Inc Un metodo para tratar la diabetes, la hiperglucemia y la hipoglucemia.
DE69904257T2 (de) * 1999-01-20 2003-04-17 Nutricia Nv Säuglingsnährpräparat
DE19906379B4 (de) * 1999-02-16 2006-05-18 Huss, Manfred Herstellung eines aggregierten Molkenproteinprodukts
GB0302929D0 (en) * 2003-02-10 2003-03-12 Inst Of Child Health Nutrient composition
CN1835762B (zh) * 2003-06-30 2010-05-12 雀巢技术公司 用于治疗和/或预防与2型糖尿病有关的功能障碍和抗胰岛素性的组合物
CA2538507A1 (en) * 2003-08-30 2005-03-10 Nestec S.A. Acid soluble proteins from micellar casein
MY153295A (en) * 2004-09-29 2015-01-29 Nestec Sa Nanoparticulated whey proteins
DE602005026456D1 (de) 2004-12-27 2011-03-31 Nestec Sa Verwendung von säuglingsnahrung mit reduziertem proteingehalt
CN102894371A (zh) 2005-07-01 2013-01-30 努特里希亚公司 含水解的蛋白质的婴儿营养品
RU2444210C2 (ru) 2005-12-23 2012-03-10 Н.В. Нютрисиа Питательные композиции для младенцев, предназначенные для предупреждения ожирения
ATE524073T1 (de) 2006-03-27 2011-09-15 Nestec Sa Molkenprotein micellen
EP1844758B1 (en) * 2006-03-27 2010-06-30 Nestec S.A. Cosmetic use of whey protein micelles
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
CN101438738A (zh) * 2007-11-23 2009-05-27 内蒙古蒙牛乳业（集团）股份有限公司 一种降血糖的酸奶及其生产方法
EP2409575B1 (en) 2008-10-17 2017-02-22 Nestec S.A. Method for making whey protein compositions
BR112012023025B1 (pt) * 2010-03-12 2021-06-01 Société des Produits Nestlé S.A. Composição nutricional, e método para mascarar sabores estranhos de leucina na mesma

Also Published As

Publication number Publication date
US10028978B2 (en) 2018-07-24
CN103906440B (zh) 2016-09-21
MX350866B (es) 2017-09-22
CN103906440A (zh) 2014-07-02
BR112014009225A8 (pt) 2017-06-20
AU2012324887B2 (en) 2015-10-29
EP2779846A1 (en) 2014-09-24
WO2013057233A1 (en) 2013-04-25
MX2014004802A (es) 2015-12-03
BR112014009225A2 (pt) 2017-06-13
US20140287056A1 (en) 2014-09-25
CL2014000865A1 (es) 2014-08-18
EP2779846B1 (en) 2017-09-06
AU2012324887A1 (en) 2014-04-03
EP2583562A1 (en) 2013-04-24
RU2014120428A (ru) 2015-11-27
RU2616525C2 (ru) 2017-04-17

Similar Documents

Publication Publication Date Title
ES2643892T3 (es) Uso de micelas de proteínas de suero de leche para niños pequeños en riesgo de obesidad o diabetes
CY1123515T1 (el) Μεθοδοι αγωγης μιας ταυπαθειας
CY1123672T1 (el) Μεθοδοι αγωγης μιας ταυπαθειας
AR095129A1 (es) Composición nutricional que comprende un hidrolizado de proteína y aminoácido con un sistema de emulsión estable
BR112014000392A2 (pt) tratamento com anticorpos anti-pcsk9
CY1121895T1 (el) Σκευασματα διαλυματος κατασκευασμενων αντισωματων anti-il-23p19
AR087881A1 (es) Metodos para reducir los niveles de lipoproteina(a) administrando un inhibidor de proproteina convertasa subtilisina kexina-9 (pcsk9)
DOP2013000299A (es) Anticuerpos anti-angptl3 y usos de los mismos
EA201592302A1 (ru) Способы снижения уровня остаточного холестерина и других фракций липопротеинов путем введения ингибитора пропротеиновой конвертазы субтилизин-кексинового типа 9 (pcsk9)
CR20130336A (es) Anticuerpo anti-pcsk9 y métodos de uso
BR112015027291A8 (pt) uso de um imunossupressor que têm uma vida eficaz farmacodinâmica especificada e composição compreendendo o referido imunossupressor
EA201590011A1 (ru) Пептидные аналоги эксендина-4
BR112014009418A2 (pt) macrociclos peptidomiméticos
BR112018072401A2 (pt) combinações de linagliptina e metformina
BR112019011144A2 (pt) compostos como agonistas peptídicos de receptor de glp1/glucagon/gip
BR112014009785A8 (pt) método para tratar ou reduzir efp
EA201300133A1 (ru) Фармацевтическая композиция и способ лечения ожирения, сопутствующих метаболических расстройств и зависимости от психоактивных веществ
CL2013003144A1 (es) Composicion que comprende a) extracto de arroz fermentado con monascus purpureus, b) un acido graso omega, c) l-carnitina y uno o mas de los siguientes: d) al menos un policosanol, e) resveratrol, f) coenzima q10 y g) al menos una vitamina, util como anticolesterolemico y antitrigliceridemico y para aumentar el colesterol hdl.
ECSP14000502A (es) Composiciones nutricionales de caseína-suero parcialmente hidrolizadas para reducir la aparición de alergias
NZ754642A (en) Beta-casein a2 and reducing or preventing symptoms of lactose intolerance
FR2971224B1 (fr) Dispositif de transport
CL2011001734A1 (es) Composición nutricional para infantes que comprende una fuente de proteína, una fuente de lípido y una fuente de carbohidrato, donde la fuente de lípido comprende ácido linoléico y ácido alfa-linolénico
BR112014009414A2 (pt) uso de micelas de proteína de soro do leite para melhorar o perfil de insulina em pacientes diabéti-cos
UA64465U (ru) Способ диагностики дисплазии соединительной ткани у больных с туберкулезом органов дыхания
Davidson Response to comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013; 36: 260–266